Lexeo Therapeutics (LXEO) Shares Issued (2022 - 2026)
Lexeo Therapeutics recorded quarterly Shares Issued of $9000.0 in Q1 2026, up 104.25% quarter-over-quarter from -$212000.0 in Q4 2025, and down 94.71% year-over-year from $170000.0 in Q1 2025.
Lexeo Therapeutics' Shares Issued history runs 5 years deep, the most recent figure standing at $9000.0 for Q1 2026.
- In Q1 2026, Shares Issued fell 94.71% year-over-year to $9000.0; the TTM figure through Mar 2026 stood at -$102000.0 (down 101.59% YoY), while the FY2025 annual figure was $59000.0, down 99.94% from the prior year.
- Shares Issued came in at $9000.0 for Q1 2026 at Lexeo Therapeutics, up from -$212000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $100.2 million in Q4 2023 to a low of -$212000.0 in Q4 2025.
- A 5-year average of $17.8 million and a median of $30000.0 in 2023 frame the typical range for Shares Issued.
- Across the five-year window, Shares Issued jumped 739508.33% in 2024 and sank 99.81% in 2025, its largest moves.
- Lexeo Therapeutics' Shares Issued stood at $28000.0 in 2022, then surged by 357757.14% to $100.2 million in 2023, then tumbled by 93.77% to $6.2 million in 2024, then tumbled by 103.39% to -$212000.0 in 2025, then jumped by 104.25% to $9000.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $9000.0, -$212000.0, and $101000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Lexeo Therapeutics | 392.12 Mn | 199.07 Mn | - | 9,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,000.00 |
| Mar 31, 2026 | 9,000.00 |
| Dec 31, 2025 | -212,000.00 |
| Dec 31, 2025 | -212,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Jun 30, 2024 | 6.25 Mn |
| Jun 30, 2024 | 6.25 Mn |
| Mar 31, 2024 | 88.75 Mn |
| Mar 31, 2024 | 88.75 Mn |
| Dec 31, 2023 | 100.20 Mn |
| Dec 31, 2023 | 100.20 Mn |
| Sep 30, 2023 | 30,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Dec 31, 2022 | 28,000.00 |